A new method of vaccine design, called the Multiple Antigen Presentation System (MAPS), may result in vaccines that bring together the benefits of whole-cell and acellular or defined subunit vaccination. The method, pioneered ...
Jul 29, 2013
0
0
At-risk people who received a single dose of the monkeypox vaccine in U.S. efforts against the virus appeared to be significantly less likely to get sick, public health officials announced Wednesday, even as they urged a ...
Sep 28, 2022
0
5
Scientists at Trinity College Dublin have made novel discoveries concerning the current vaccine against whooping cough that may lead to the development of an improved future vaccine. The findings could help reduce the incidence ...
May 13, 2013
0
0
Efficient immune protection requires the ability to rapidly recognize intruders that the body has encountered in the past. This is achieved via 'memory' B cells, which develop following immune system activation by a virus, ...
Feb 15, 2013
0
0
Some coronaviruses can add to their genetic pool some genes belonging to the host they infected. In this way, they can blend in and be less detectable to the immune system. This discovery was published in the journal Viruses ...
Feb 8, 2021
0
5
Researchers from Duke University have developed a nasal vaccine formulation that provides protective immunity against West Nile virus (WNV) infection in mice after only 2 doses. They present their findings at the 2014 American ...
Jan 28, 2014
0
0
Researchers of Utrecht University, Intravacc and the National Institute of Public Health and Environmental Protection used a new method to identify hitherto unknown peptide antigens. This type of antigen had long been searched ...
Mar 18, 2014
0
0
Preclinical, laboratory studies suggest a novel immunotherapy could potentially work like a vaccine against metastatic cancers, according to scientists at Virginia Commonwealth University Massey Cancer Center. Results from ...
Feb 27, 2013
0
0
(Medical Xpress) -- Infections from certain parasites can compromise the immune system, leaving it less able to fight other diseases.
Jun 28, 2012
0
0
In a recent study, scientists have concluded that the cure rates of Miltefosine, the only oral drug for visceral leishmaniasis available, have significantly decreased. Miltefosine was introduced in the Indian subcontinent ...
Mar 1, 2013
0
0
